Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 7.11.2009 | EN | Official Journal of the European Union | C 267/70 |

---

Action brought on 25 August 2009 — Novartis v OHIM — Sanochemia Pharmazeutika AG

(Case T -331/09)

2009/C 267/128

Language in which the application was lodged: German

Parties

Applicant: Novartis AG (Basel, Switzerland) (represented by: N. Hebeis, lawyer)

Defendant: Office for Harmonisation in the Internal Market (Trade Marks and Designs)

Other part to the proceedings before the Board of Appeal of OHIM: Sanochemia Pharmazeutika AG

Form of order sought

|  |  |
| --- | --- |
| — | Annul the decision of the First Board of Appeal of the Office for Harmonisation in the Internal Market (Trade Marks and Designs) of 18 June 2009 in Case R 1601/2007-1; and |

|  |  |
| --- | --- |
| — | Order the Office for Harmonisation in the Internal Market to pay the costs. |

Pleas in law and main arguments

Applicant for a Community trade mark: Sanochemia Pharmazeutika AG

Community trade mark concerned: the word mark, ‘TOLPOSAN’ for goods in Class 5 (Registration No 4 134 383)

Proprietor of the mark or sign cited in the opposition proceedings: the applicant

Mark or sign cited in opposition: the international registration of the word mark ‘TONOPAN’ for goods in Class 5 (No 227 508)

Decision of the Opposition Division: Opposition dismissed

Decision of the Board of Appeal: Appeal dismissed

Pleas in law: Infringement of Article 8(1)(b) of Regulation (EC) No 207/2009[(1)](#ntr1-C_2009267EN.01007001-E0001), since there is no likelihood of confusion between the trade marks at issue.

---

[Top](#document1)